Imbio PHA (4.0.0) vs Withings Scan Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by Withings

AI Verdict

These two tools are adjacent rather than direct competitors, as they address different aspects of cardiac health using distinct methodologies. Imbio PHA is an AI-powered software designed for detailed diagnostic analysis of CT pulmonary angiogram scans to assess specific cardiac structures and aid in the diagnosis of pulmonary embolism and hypertension. In contrast, Withings Scan Monitor is a device-based solution (smart scales, smartwatches) focused on remote patient monitoring and personal health tracking, offering features like ECG for AFib detection and other vital health metrics.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your clinical practice requires automated, AI-driven analysis of CT pulmonary angiogram (CTPA) scans. This tool is ideal for rapidly assessing cardiac structures, such as right and left ventricular dilation, to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension within a radiology or cardiology workflow. It provides precise measurements and summary reports directly from imaging data, enhancing diagnostic efficiency.

View Imbio PHA (4.0.0) →

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you need a user-friendly, device-based solution for continuous personal health tracking or remote patient monitoring. This tool excels at providing regular vital health metrics, including FDA-cleared ECG for AFib detection, heart rate, and body composition, directly from smart scales and smartwatches. It's perfect for individuals managing their health proactively or for clinicians seeking accessible, ongoing patient data outside of traditional clinical settings.

View Withings Scan Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Withings Scan Monitor
Pricing Unknown Device purchase with optional subscription for enhanced features and clinical services.
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Device-based (smart scale, smartwatch) with cloud synchronization and mobile application.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Tool B (Withings Scan Monitor) is designed for broad consumer use, emphasizing ease of use with device-based monitoring, cloud synchronization, and a mobile application, aligning with its tagline of 'technology that people love'. While Tool A (Imbio PHA) integrates into complex clinical workflows, Tool B's focus on intuitive, accessible design for a wider audience gives it an edge in general usability.

Clinical Value

Imbio PHA (4.0.0)

Tool A (Imbio PHA) provides highly specialized, quantitative measurements from CTPA scans to aid in the diagnosis and risk stratification of acute and critical conditions like pulmonary embolism and hypertension. While Tool B (Withings Scan Monitor) offers valuable continuous monitoring for AFib and general health, Tool A's direct impact on diagnostic decisions for life-threatening conditions from complex imaging represents a higher-stakes clinical value.

Pricing & Value

Withings Scan Monitor

Tool B (Withings Scan Monitor) offers transparent pricing with a clear device purchase cost and an optional subscription for enhanced features, allowing users to easily assess its value proposition. Tool A (Imbio PHA) requires direct contact for pricing, which is typical for enterprise solutions but makes it impossible to evaluate its pricing and value without engaging the vendor.

Enterprise Readiness

Imbio PHA (4.0.0)

Tool A (Imbio PHA) is explicitly designed for enterprise deployment, offering cloud, on-premise, or partner integration options, and is third-party certified HIPAA compliant. Its integration with native DICOM tools and workflows demonstrates a strong readiness for large-scale healthcare IT environments, which is a more robust enterprise offering than Tool B's device-based RPM capabilities.

Innovation

Withings Scan Monitor

Tool B (Withings Scan Monitor) demonstrates significant innovation by integrating multiple advanced health sensors and AI (e.g., 6-lead ECG, vascular age, nerve health) into accessible consumer devices like smart scales and smartwatches for continuous, multi-parameter monitoring. While Tool A (Imbio PHA) innovates in automating complex image analysis, Tool B's approach to democratizing advanced health monitoring in consumer devices is more broadly disruptive.

Support & Docs

Withings Scan Monitor

Tool B (Withings Scan Monitor) offers a comprehensive suite of support options including in-app support, a detailed help center with user guides and troubleshooting, a community forum, and live chat support in multiple languages. Tool A (Imbio PHA) provides user manuals and direct email support, which is standard for enterprise software, but lacks the breadth of accessible, multi-channel support that Withings offers to its diverse user base.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Withings Scan Monitor
Name Imbio PHA (4.0.0) Withings Scan Monitor
Description FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
Company Imbio Withings
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes). 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan); Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch); Heart rate measurement and irregular rhythm notifications; Blood oxygen saturation (SpO2) measurement (ScanWatch); Vascular Age assessment (Body Scan); Nerve Health Score (Electrodermal Activity) (Body Scan); Segmental body composition analysis (Body Scan); Automatic data synchronization via Wi-Fi and Bluetooth.

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Withings Scan Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA is an FDA-cleared AI-powered software designed to automatically measure cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Withings Scan Monitor, integrated into smart scales and smartwatches, offers FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
Imbio PHA specifically utilizes CT pulmonary angiogram (CTPA) scans for its analysis, processing medical images to measure cardiac structures. In contrast, Withings Scan Monitor collects data from device-based wearables, such as smart scales and smartwatches, to provide ECG, heart rate, blood oxygen saturation (SpO2), and other health metrics.
Imbio PHA offers flexible deployment options including Cloud, Enterprise (on-premise), or via partners, and integrates with native DICOM tools and workflows, generating annotated DICOM images and PDF summary reports. Withings Scan Monitor is device-based, with automatic data synchronization via Wi-Fi and Bluetooth to a mobile application and cloud for remote patient monitoring.
Imbio PHA automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios. Withings Scan Monitor provides 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan) or single-lead ECG for AFib detection (ScanWatch), heart rate measurement, irregular rhythm notifications, and blood oxygen saturation (SpO2) measurement.
AI Tool Finder
AI-powered search. Results may not be comprehensive.